Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05165433 |
|---|---|
| Brief Title: | Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY) (FORTIFY) |
| First Submitted : | December 7, 2021 |
| First Submitted that Met QC Criteria : | December 7, 2021 |
| First Posted : | December 21, 2021 |
| Last Update Submitted that Met QC Criteria : | January 16, 2023 |
| Last Update Posted : | January 18, 2023 |